QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q: What does CUSIP 74754R103 represent in this 13F holders report?

CUSIP 74754R103 is the security identifier for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q4 2022?

No institutional holders were reported for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q4 2022; review adjacent reporting periods for trend context.

CUSIP: 74754R103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,138,804
Total 13F shares: 0
Share change: -2,314,772
Total reported value: $0
Number of holders: 0
Value change: -$619,043
Number of sells: 22

Quarterly Holders Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2022

Recent filing periods for CUSIP 74754R103:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q4 2022 13F Holders as of 31 Dec 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q4 2022.